Pulmonary Embolism
Disease State Hub
Featured
08/06/2026
Anthony Calabro, MA
In the double-blind EPCAT III RCT, aspirin alone was noninferior to 5 days of rivaroxaban followed by aspirin for preventing symptomatic VTE after total hip or knee arthroplasty, with no clinically relevant...
08/06/2026
05/11/2026
Ashton L. Stahl
In intermediate-risk pulmonary embolism, catheter-directed fibrinolysis lowered early
clinical deterioration vs anticoagulation alone.
05/11/2026
08/09/2025
Anthony Calabro, MA
Patients who used statins for at least 4 weeks prior to total hip arthroplasty experienced significantly lower rates of venous thromboembolism within 90 days postoperatively. No significant differences were...
08/09/2025
News
08/06/2026
Anthony Calabro, MA
In the double-blind EPCAT III RCT, aspirin alone was noninferior to 5 days of rivaroxaban followed by aspirin for preventing symptomatic VTE after total hip or knee arthroplasty, with no clinically relevant...
08/06/2026
05/11/2026
Ashton L. Stahl
In intermediate-risk pulmonary embolism, catheter-directed fibrinolysis lowered early
clinical deterioration vs anticoagulation alone.
05/11/2026
08/09/2025
Anthony Calabro, MA
Patients who used statins for at least 4 weeks prior to total hip arthroplasty experienced significantly lower rates of venous thromboembolism within 90 days postoperatively. No significant differences were...
08/09/2025
08/06/2018
Gender differences associated with pulmonary embolism have been unclear and controversial.
08/06/2018
02/14/2018
In a new study, researchers evaluated the safety of pulmonary embolism rule-out criteria for the ruling out of subsequent thromboembolic events in low-risk patients who presented to the emergency...
02/14/2018
Clinical Insights
01/31/2023
In this podcast, Victor J Test, MD, and Parth Rali, MD, MBBS, talk about controversies in the diagnosis and management of acute pulmonary embolism, including the use of inferior vena cava filters in...
01/31/2023
02/13/2022
In this podcast, Mary Looby, PharmD, and Christopher S. King, MD, speak about the use of direct oral anticoagulants for the treatment of venous thromboembolic disease and the duration of anticoagulation...
02/13/2022
01/24/2022
Bhavin Dalal, MD; Vijay Balasubramanian, MD
In this podcast, Bhavin Dalal, MD, and Vijay Balasubramanian, MD, talk about controversies in the diagnosis and management of acute pulmonary embolism, including intermediate-risk pulmonary embolism and a...
01/24/2022